Clinical Trial Update: Presbyopic Supracor Treatment for Near Myopic/Hyperopic Pseudophakic Eyes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Supracor presbyopic treatment for near-sighted or far-sighted pseudophakic eyes; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperopia
• Myopia
• Presbyopia

Drugs mentioned

• Supracor

Snippet

Sponsor: Technolas Perfect Vision GmbH | Conditions: Myopia, Hyperopia | Phase 4 | Status: COMPLETED